Caribou Biosciences

Caribou Biosciences is developing CRISPR technologies to create allogeneic cell therapies for oncology. Caribou has built CRISPR hybrid RNA-DNA (chRDNA), their proprietary technology that enables highly efficient, highly specific genome editing. chRDNA is then used to develop sophisticated genome-edited cell therapies. For example, Caribou is using chRDNA to create next-generation allogeneic CAR-T and CAR-NK cell therapies to enhance the longevity and persistence of the cells. Scientific advances have been published in high-impact journals. Caribou has one ongoing Phase I clinical trial to evaluate CB-010 in adults with relapsed B cell non-Hodgkin lymphoma.

Jobs:

Senior Scientist, Analytical Development

Berkeley, CA|11 days ago

Apply

Process Development Associate

Berkeley, CA|11 days ago

Apply

Senior Process Development Associate

Berkeley, CA|11 days ago

Apply

Senior Research Associate, Pharmacology

Berkeley, CA|19 days ago

Apply

Director of Quality Assurance, GMP

Berkeley, CA|20 days ago

Apply

Scientist, Analytical Development

Berkeley, CA|24 days ago

Apply

Research Associate, Pharmacology

Berkeley, CA|29 days ago

Apply

Vice President of Commercial Strategy

Berkeley, CA|45 days ago

Apply

Medical Director/Senior Medical Director

Berkeley, CA|61 days ago

Apply

Director of Clinical Pharmacology

Remote|93 days ago

Apply

Senior Scientist, CAR-NK Therapeutics

Berkeley, CA|100+ days ago

Apply

Scientist, CAR-NK Therapeutics

Berkeley, CA|100+ days ago

Apply

Director of Regulatory Affairs

Berkeley, CA|100+ days ago

Apply